Investors Overview
Company Profile
Knight Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, in-licensing, out-licensing, marketing and distributing innovative prescription pharmaceuticals, consumer health products and medical devices in Canada and Latin America. Knight is publicly traded on the TSX (GUD).
Stock Snapshot
Head Office
3400 de Maisonneuve W.
Suite 1055
Montreal, QC Canada H3Z 3B8
Investor Relations
Samira Sakhia
President and Chief Financial Officer
info@gudknight.com
Analyst Coverage
Cormark Securities
Stifel GMP
Justin Keywood
jkeywood@stifel.com
Paradigm Capital